AvantiCell Science company

AvantiCell delivers leading-edge solutions for customers wishing to evaluate bio-activity or bio-safety in a wide-range of test materials; from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials. AvantiCell solutions use advanced cell culture technology based on physiologically-relevant human and animal cells. AvantiCell supplies a growing range of human primary cell products which are accessible as cell isolates requiring re-culture within the customer's laboratory or in the form of pre-assembled, cryopreserved models. These products make cell-based analysis available to all customers in a plug-and-play format. AvantiCell also provides its expertise in a range of services ranging from off-the-shelf cell-based assays to specialist cell culture systems customised to meet customers’ requirements.
Technology: P4 Medicine
Industry: Personalized Medicine
Headquarters: Ayr, South Ayrshire, United Kingdom
Founded Date: 2006
Employees Number: 11-50
Funding Status: N/A
Investors Number: 1
Total Funding: €1.3M
Estimated Revenue: $1M to $10M
Last Funding Type: Grant

Visit Website
Register and Claim Ownership